Status:
COMPLETED
Eating Disorders in Type 1 Insulin-dependent Diabetes Patients
Lead Sponsor:
Icadom
Collaborating Sponsors:
AGIR à Dom
Conditions:
Type 1 Diabetes
Eating Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the prevalence of eating disorders in type 1 insulin-dependent diabetes patients
Detailed Description
The risk of developing an eating disorder is increased in type 1 diabetes patients and associated with a poor prognosis in terms of glycemic control, metabolic complications, degenerative complication...
Eligibility Criteria
Inclusion
- Adult patient over 18 years of age with type 1 diabetes treated with a subcutaneous insulin pump
- Patient followed up for a subcutaneous insulin pump treatment by the healthcare provider, participating in the study (Agir à Dom group).
- Beneficiary of social security coverage.
Exclusion
- Patient with type 2 diabetes or MODY diabetes
- Patient wearing a pacemaker
- Breastfeeding or pregnant woman
- Deprived of liberty by judicial or administrative decision
- Legal guardianship
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04506216
Start Date
September 1 2020
End Date
December 23 2021
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AGIR à dom.
Meylan, France, 38240